Lithium As a Prophylactic Agent
Authors:
- Poul Christian BaastrupPBPoul Christian Baastrup
- Schou MogensSMSchou Mogens
- 1 February 1967
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 16 (2) , 162-172
Abstract
THE SPECIFIC therapeutic effect of lithium in manic phases of the manicdepressive psychosis was first observed in 19491and was confirmed later in controlled studies,2,3as well as in a number of uncontrolled ones. A prophylactic action of the drug against both the manic and depressive phases of the illness could be noted in a few of the patients described by Schou et al.2More systematic and detailed observations of this effect were made independently by Hartigan4and Baastrup,5and the termnormothymoticswas proposed for drugs with a specific action against manic-depressive psychosis.6 In order to demonstrate prophylactic drug action in a disorder such as manicdepressive psychosis, which is characterized by a capricious and largely unpredictable course, one must study a large number of patients who have a sufficiently high risk of relapse and who are observed forKeywords
This publication has 4 references indexed in Scilit:
- Normothymotics, “Mood-Normalizers”The British Journal of Psychiatry, 1963
- The use of Lithium Salts in Affective DisordersThe British Journal of Psychiatry, 1963
- BIOLOGY AND PHARMACOLOGY OF THE LITHIUM IONPharmacological Reviews, 1957
- THE TREATMENT OF MANIC PSYCHOSES BY THE ADMINISTRATION OF LITHIUM SALTSJournal of Neurology, Neurosurgery & Psychiatry, 1954